Metformin Use is Associated with Improved Survival for Patients with Advanced Prostate Cancer on Androgen Deprivation Therapy

Metformin is commonly prescribed for patients with type 2 diabetes mellitus. We hypothesized that metformin plus androgen deprivation therapy may be beneficial in combination. Our objective was to assess this combination in a retrospective cohort of patients with advanced prostate cancer.

Source: The Journal of Urology - June 22, 2018 Category: Urology & Nephrology Authors: Kyle A. Richards, Jinn-ing Liou, Vincent L. Cryns, Tracy M. Downs, E. Jason Abel, David F. Jarrard Tags: Adult Urology Source Type: research